Sun Pharmaceutical Industries is trading lower by 3.3% at Rs 507after its Israel subsidiary Taro Pharmaceutical Industries has reported a 6.5% year-on-year drop in its net profit for the quarter ended June 30, 2013 (Q1).
The company’s net income for the three month period ended June 30, 2013 declined to $58.8 million from $62.9 million in the year ago quarter, Taro Pharma said in statement.
Net sales for the quarter declined 3.8% to $153.2 million from $159.2 million during the corresponding quarter of previous fiscal, it added.
Meanwhile, Sun Pharma will announce its first quarter earnings on tomorrow (August 9).
The stock opened at Rs 512 and hit a low of Rs 495 on NSE. A combined 2.48 million shares changed hands on the counter till noon deals on NSE and BSE.
The company’s net income for the three month period ended June 30, 2013 declined to $58.8 million from $62.9 million in the year ago quarter, Taro Pharma said in statement.
Net sales for the quarter declined 3.8% to $153.2 million from $159.2 million during the corresponding quarter of previous fiscal, it added.
Meanwhile, Sun Pharma will announce its first quarter earnings on tomorrow (August 9).
The stock opened at Rs 512 and hit a low of Rs 495 on NSE. A combined 2.48 million shares changed hands on the counter till noon deals on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%